Ruanhong Cai

Qiao Li 1 collaboration

Xiuwen Guan 1 collaboration

Shanshan Chen 1 collaboration

Zongbi Yi 1 collaboration

Bo Lan 1 collaboration

Puyuan Xing 1 collaboration

Ying Fan 1 collaboration

Jiayu Wang 1 collaboration

Yang Luo 1 collaboration

Peng Yuan 1 collaboration

Ruigang Cai 1 collaboration

Pin Zhang 1 collaboration

Qing Li 1 collaboration

Dafang Zhong 1 collaboration

Yifan Zhang 1 collaboration

Jianjun Zou 1 collaboration

Xiaoyu Zhu 1 collaboration

Fei Ma 1 collaboration

Binghe Xu 1 collaboration

Miaomiao Zhang 1 collaboration

Lulu Zhao 1 collaboration

Fengting Du 1 collaboration

Yunchao Wu 1 collaboration

Rong Cai 1 collaboration

Lixia Xu 1 collaboration

Hongrui Jin 1 collaboration

Shengqiang Zou 1 collaboration

Aihua Gong 1 collaboration

Fengyi Du 1 collaboration

Wang Zheng 1 collaboration

Xiaoyong Yang 1 collaboration

Ruikun Hu 1 collaboration

Ruiqi Cai 1 collaboration

Laura Hofmann 1 collaboration

Zhifei Wang 1 collaboration

Qiaolin Hu 1 collaboration

Xiong Liu 1 collaboration

David Bulkley 1 collaboration

Yong Yu 1 collaboration

Jingfeng Tang 1 collaboration

Veit Flockerzi 1 collaboration

Ying Cao 1 collaboration

Erhu Cao 1 collaboration

Xing-Zhen Chen 1 collaboration

Publications (3)

Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients: A Phase I Clinical Trial.

Facile synthesis of cerium-doped carbon quantum dots as a highly efficient antioxidant for free radical scavenging.

Author Correction: Hydrophobic pore gates regulate ion permeation in polycystic kidney disease 2 and 2L1 channels.

Réseau de co-auteurs